These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12785160)

  • 1. Role of mitotic counts in the grading and prognosis of the breast cancer.
    Patel C; Sidhu KP; Shah MJ; Patel SM
    Indian J Pathol Microbiol; 2002 Jul; 45(3):247-54. PubMed ID: 12785160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours.
    Fiets WE; Bellot FE; Struikmans H; Blankenstein MA; Nortier JW
    Eur J Surg Oncol; 2005 Mar; 31(2):128-33. PubMed ID: 15698727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems.
    Genestie C; Zafrani B; Asselain B; Fourquet A; Rozan S; Validire P; Vincent-Salomon A; Sastre-Garau X
    Anticancer Res; 1998; 18(1B):571-6. PubMed ID: 9568179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
    Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation in African breast cancer: biology and prognostication in nigerian breast cancer material.
    Ikpatt OF; Kuopio T; Collan Y
    Mod Pathol; 2002 Aug; 15(8):783-9. PubMed ID: 12181262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up.
    Bult P; Manders P; Straatman HM; Tjan-Heijnen VC; Beex LV; Hendriks J; Leer JW; Verbeek AL; Holland R
    Breast Cancer Res Treat; 2010 Jul; 122(1):77-86. PubMed ID: 19760038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume corrected mitotic index (M/V index), mitotic activity index (MAI), and histological grading in breast cancer.
    Lipponen PK; Collan Y; Eskelinen MJ
    Int Surg; 1991; 76(4):245-9. PubMed ID: 1663917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.
    Skaland I; van Diest PJ; Janssen EA; Gudlaugsson E; Baak JP
    Hum Pathol; 2008 Apr; 39(4):584-90. PubMed ID: 18291440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers.
    Baak JP; Gudlaugsson E; Skaland I; Guo LH; Klos J; Lende TH; Søiland H; Janssen EA; Zur Hausen A
    Breast Cancer Res Treat; 2009 May; 115(2):241-54. PubMed ID: 18665447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.
    Baak JP; Colpaert CG; van Diest PJ; Janssen E; van Diermen B; Albernaz E; Vermeulen PB; Van Marck EA
    Eur J Cancer; 2005 Sep; 41(14):2093-101. PubMed ID: 16153819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the prognostic significance of current and modified histological grades in breast carcinomas.
    Charpin C; Bacquie N; Bouvier C; Devictor B; Boulat J; Andrac L; Lavaut MN; Allasia C; Piana L
    Anticancer Res; 1995; 15(6B):2611-7. PubMed ID: 8669834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly proposed semi-automated method of grading invasive lobular carcinoma: a unifying concept and correlation with prognostic markers and patient survival.
    Stevens E; Kimler BF; Davis MK; Fan F; Thomas P; Wang XY; Damjanov I; Tawfik OW
    Ann Clin Lab Sci; 2009; 39(1):25-31. PubMed ID: 19201737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
    Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
    Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
    Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
    Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent.
    Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA; Gudlaugsson E;
    Eur J Cancer; 2007 Feb; 43(3):527-35. PubMed ID: 17110097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?
    Trihia H; Murray S; Price K; Gelber RD; Golouh R; Goldhirsch A; Coates AS; Collins J; Castiglione-Gertsch M; Gusterson BA;
    Cancer; 2003 Mar; 97(5):1321-31. PubMed ID: 12599241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.
    Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA
    J Clin Oncol; 2005 Sep; 23(25):5993-6001. PubMed ID: 16135467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasis.
    Westenend PJ; Meurs CJ; Damhuis RA
    J Clin Pathol; 2005 Feb; 58(2):196-201. PubMed ID: 15677542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.